Trials / Completed
CompletedNCT00037648
Juvenile Rheumatoid Arthritis
A Randomized, Multi-center, Blinded, Placebo-controlled Study With an Open-label Run-in Period to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daily, Single, Subcutaneous Injections of r-metHuIL-1ra (Anakinra) in Polyarticular-Course Juvenile Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 2 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety of anakinra in patients with Polyarticular-Course Juvenile Rheumatoid Arthritis, a form of rheumatoid arthritis affecting children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anakinra | anakinra |
| DRUG | Placebo | placebo |
Timeline
- Start date
- 2000-07-01
- Primary completion
- 2003-11-01
- Completion
- 2003-11-01
- First posted
- 2002-05-20
- Last updated
- 2009-11-26
Source: ClinicalTrials.gov record NCT00037648. Inclusion in this directory is not an endorsement.